Slow arrhythmia
Conditions
Interventions
Experimental Group:Yang-warming and blood-activating formula decoction
Control Group:Heart Treasure Pill
Sponsors
China Academy of Traditional Chinese Medicine, Xiyuan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meets diagnostic criteria for sinoatrial node dysfunction or atrioventricular conduction block; 2. Exhibits corresponding clinical symptoms such as dizziness, transient visual obscurations, fatigue, palpitations, or chest oppression, and considers symptom episodes clearly related to bradycardia; 3. Patient refuses pacemaker therapy; 4. Meets diagnostic criteria for yang deficiency and blood stasis syndrome; 5. Age between 18 and 75 years old; 6. Willing to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Dynamic electrocardiogram indicates the longest RR interval >3 seconds or the lowest heart rate 160 mmHg or diastolic >100 mmHg); 5. Drug-induced transient secondary bradycardia; 6. Bradycardia caused by hypothyroidism; 7. Glaucoma; 8. Pregnant or breastfeeding women; 9. Suffering from anxiety, depression, or other mental disorders; 10. Coagulation dysfunction; 11. Allergy to the investigational drug; 12. Participation in other clinical trials within the past month; 13. Other conditions deemed unsuitable for participation in the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lowest heart rate;After 8 weeks of treatment, the symptom-specific VAS scores changed compared to baseline by =13 mm.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Rate Variability Index;Health Condition Questionnaire;Cost-Effectiveness Analysis;Infrared Heatmap;Full-cycle dynamic tongue appearance monitoring; | — |
Countries
China
Contacts
Public ContactZhang Wantong
China Academy of Traditional Chinese Medicine, Xiyuan Hospital
Outcome results
None listed